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Male infertility problems can occur when sperms are limited in number or function. In this paper, we describe the clinical
evaluation of male infertility. A detailed history, physical examination, and basic semen analysis are required. In addition,
ultrasound,karyotyping,andhormonalstudiesareneededtodeterminespeciﬁccausesofinfertility.Inaddition,theWorldHealth
Organization (WHO, 2009) has developed a manual to provide guidance in performing a comprehensive semen analysis. Among
the possible reasons for male infertility, nonobstructive azoospermia is the least treatable, because few or no mature sperm may be
produced. In many cases, men with nonobstructive azoospermia typically have small-volume testes and elevated FSH. Although
treatmentmaynotcompletelyrestorethequalityofsemenfrommenwithsubnormalfertility,insomecasesasuccessfulpregnancy
can still be achieved through assisted reproductive technology.
1.Introduction
About 1 in 7 couples have problems conceiving, with a
similar incidence worldwide. Over 80% of couples who have
regular sexual intercourse and do not use contraception will
achieveapregnancywithinoneyear,andapproximately92%
can achieve a pregnancy within 2 years [1]. Infertility aﬀects
malesandfemalesequally,althoughmanypeoplebelievethat
infertility is a female problem. In Japan, especially, couples
oppose insemination or adoption as an alternative to having
a child carrying both parents’ genes, which means that males
are likely to seek infertility evaluations when a couple has
diﬃculty conceiving.
The clinical evaluation of male infertility includes a
detailed history, physical examination, laboratory tests,
ultrasound study, and karyotyping. The two main purposes
of the evaluation are (1) to identify any modiﬁable factors
that can improve the man’s fertility status and (2) to identify
any serious underlying conditions, such as testis cancer,
osteoporosis,andendocrineorgeneticproblemsthatpresent
ﬁrst as infertility [2].
2. History-Taking for the Male
Infertility Workup
The infertility history should include a detailed account of
the patient’s reproductive and sexual history, developmental,
family, medical, and surgical history. The information to be
included in each portion of the history is detailed below.
2.1. Reproductive and Sexual History. For the reproductive
history, any prior conceptions for the male with present
or past partners, details of any prior diﬃculty achieving
conception, past evaluations and treatments for infertility,
and previous use of contraception should all be recorded,
along with the frequency and timing of intercourse with
the man’s current partner. Information about erectile and
ejaculatory function and frequency of masturbation should
be requested, as well as the timing of ﬁrst masturbation and
intercourse.
2.2. Developmental History. A history of speciﬁc childhood
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bilateral cryptorchidism causes a signiﬁcant decrease in
spermatogenesis, but unilateral cryptorchidism usually has
much less impact. Studies of patients who underwent
orchiopexy to treat cryptorchidism report decreased sperm
densities in about 30% of men, on average, with unilat-
eral cryptorchidism (range 28–82%), although two studies
have reported abnormal sperm densities in only 17% of
patients [3, 4]. In contrast, an average of about 50% of
patients with bilateral cryptorchidism (range 9–88%) show
decreased sperm densities. Despite the trend of performing
orchidopexies at an earlier age, improved fertility rates have
yet to be demonstrated with this approach. On the other
hand, testes that remain undescended after puberty do not
function,andfertilityratesarenotimprovedbypostpubertal
repair [5, 6].
Testicular trauma or a history of torsion should be noted,
since both may result in atrophic testes. Approximately
30–40% of men with a history of testicular torsion have
abnormal results upon semen analysis [7–14]. In up to 11%
of patients with testicular torsion, antisperm antibodies are
present at the time of or after the event [15, 16].
The timing of pubertal development should be noted.
Signiﬁcantly delayed or incomplete development may sug-
gest an endocrinopathy. In addition, although early child-
hood mumps does not appear to aﬀect the testis, after
the age of 11 or 12, 30% of male patients who contract
mumps develop unilateral orchitis. Bilateral orchitis occurs
in approximately 10% of peripubertal and adult males who
contract mumps [17]. Unilateral and bilateral orchitis from
mumps can cause severe testicular damage.
2.3. Medical History. Diabetes may aﬀect erectile and/or
ejaculatory function [18], and any systemic illness accom-
panied by fever or viremia can lead to impaired testicular
function, although the eﬀects may not be measurable in
the ejaculate for 1–4 months. A history of pyospermia or
prostatitis should be noted, although both are uncommon
and neither is proved to cause infertility [19]. Primary ciliary
dyskinesia (also known as immotile cilia syndrome), which
should be suspected when there is a history of chronic upper
respiratory infections, causes severe defects in sperm motil-
ity. When this condition is associated with situs inversus, it is
knownasKartagenersyndrome,whichisararecauseofmale
infertility [20]. Frequent respiratory infections associated
with azoospermia raise the possibility of Young syndrome
[21], in which epididymal obstruction is caused by the
inspissation of secretions. Neurologic issues can lead to male
infertility as a variety of hormonal abnormalities including
thyroiddisorders, hyperprolactinemia,andelevatedestrogen
levels. Finally, any history of urinary tract infections or
sexually transmitted disease should be recorded, particularly
if associated with epididymitis, as these conditions can lead
to epididymal obstruction.
2.4. Past Surgical History and Cancer Treatments. Details of
past surgeries should be obtained. Pelvic and retroperitoneal
surgery may impair ejaculatory function.
Patients with testicular cancer may present with infer-
tility either before or after treatment. Approximately, 50%
of testicular cancer patients have subnormal sperm den-
sities prior to chemotherapy [11, 13, 22, 23]. Following
cisplatinum-based chemotherapy for testicular cancer, most
patients will develop azoospermia. However, most will
r e c o v e rs p e r mp r o d u c t i o nw i t h i nf o u ry e a r s[ 24, 25]. Most
patients with lymphoma, leukemia, or sarcoma become
permanent sterility after chemotherapy.
2.5. Medication and Drug Use. A detailed history of med-
ications should be obtained. Unfortunately, for many sub-
stances, data detailing potential eﬀects on male fertility are
lacking. Online sources include databases such as Reprotox
and Reprotext. Both are often available through online
hospital and university databases. Exogenous androgens are
well known to induce hypogonadotropic hypogonadism,
whichmaybeinduceddirectlybytestosteroneorbysynthetic
anabolic steroids. The subsequent suppression of endoge-
nous testosterone production usually results in azoospermia,
which is frequently reversible over a 3–6-month period.
Importantly, some patients do not recover normal pituitary
function.
2.6. Lifestyle Exposure. Exposure to potential environmental
toxins including pesticides, mercury, cadmium, arsenic, and
hydrocarbons can impair spermatogenesis. In particular,
the soil fumigants amebicide and nematocide, and 2-
bromopropane (a substitute for chloroﬂuorocarbons) can
cause decreased spermatogenesis [26–32]. Alcohol depen-
dency is frequently associated with testicular atrophy, but
moderate alcohol consumption does not appear to impair
fertility [33–36]. The eﬀect of cigarette smoking on male
infertility remains controversial, with some studies showing
decreased semen health and others showing no eﬀect [37–
43].However,thesumoftheaccumulatingevidencesuggests
that cigarettes smoking can impact male fertility.
3.PhysicalExamination
The physical examination for male infertility should focus
on identifying abnormalities that could aﬀect fertility.
Endocrine disorders should be suspected in cases of abnor-
mal androgenization. Gynecomastia can result from exces-
sive estrogens, an improper estrogen-to-androgen ratio, or
elevated prolactin levels. Penile curvature, angulation, and
the location of the urethral meatus should be assessed.
The scrotum should be carefully palpated with the patient
standing, noting the size and consistency of the testicles; the
room should be kept warm for this exam.
The testicle size can be measured with an orchidometer.
This measurement is important because impaired spermato-
g e n e s i so f t e na c c o m p a n i e ss m a l l - v o l u m et e s t e s[ 44]. The
normal volume is at least 20mL [45, 46]. Note, however,
that Asian men typically have smaller testes than men of
other races. The epididymis should be examined carefully,
noting the presence of the caput, corpus, and cauda as well as
whether the epididymis feels full or indurated. Fullness can
suggest obstruction of the genital ducts.Advances in Urology 3
Table 1: Semen parameters.
Volume >1.5mL
Sperm concentration >15million/mL
Total sperm count per ejaculate 39million
Sperm progressive motility >32%
Total sperm motility >40%
Sperm vitality >58% alive
Normal morphology >3%
WBC (white blood cells) <1million/mL
During palpation of the spermatic cords, the clinician
should conﬁrm the presence or absence of the vas deferens
and note any vasal atrophy or nodularity, or the presence of
a varicocele within the spermatic cord and surrounding the
testicle. An enlarged venous diameter can be detected with
the patient performing the Valsalva maneuver. Alternatively,
the patient can often increase intra-abdominal pressure
without contracting the cremaster muscles, by distending
the abdomen. Varicoceles are graded as small (grade I)
if palpable only when the patient performs the Valsalva
maneuver, moderate (grade II) if palpable when the patient
is standing but does not perform the Valsalva maneuver, and
large (grade III) when veins can be seen through the scrotal
skin. Varicoceles should decrease in size when the patient is
in the supine position.
4.LaboratoryTests
After the above exams have been completed, appropriate
laboratory tests should be performed. The ﬁrst step in
laboratory testing is to identify patients who are likely to be
infertile, subfertile, and fertile, for which only semen analysis
isrequired.Sincemostinfertilemenhavesomemotilesperm
in the semen, threshold values are used to indicate whether
fertility is more or less likely. Azoospermic patients, however,
are sterile. Importantly, although the number of motile
sperm is suggestive of fertility, there can be considerable
variation in the fertility of men with equal motile sperm
counts.
4.1.SemenAnalysis. TheWorldHealthOrganization(WHO,
2009) has published a guide to semen analysis in humans.
Because semen parameters ﬂuctuate from day to day, at least
two semen samples are usually required to diagnose below-
normal semen quality. A recent study of over 4500 samples
from men living in four continents was used to determine
the referencerange for adults.The lower referencelimits (5th
percentile) for semen parameters in “fertile” adult men are
given in Table 1 [47].
4.1.1. Collection. Patients should be given speciﬁc instruc-
tions on collecting semen specimens for analysis. Semen is
collected by masturbation. Patients should be encouraged to
abstain from ejaculation for 72 hours prior to collecting a
semen sample in the laboratory. We provide adult videos and
books for patients in a room dedicated to semen collection.
The specimen container should be clean, although sterility
is not required, and wide-mouthed, to minimize collection
error. The specimen should be transported to the laboratory
at room temperature. Note that fresh semen is a coagulum
that liqueﬁes 5–25min after ejaculation.
4.1.2. Concentration. The term, “sperm count,” typically re-
fers to sperm density, reported as millions of sperm per
milliliter of semen. “Total sperm count” refers to the total
number of sperm in the ejaculate.
4.2. Interpretation of the Initial Evaluation. Once the data
from the physical examination, history, and semen anal-
ysis have been acquired, a diﬀerential diagnosis should
be developed. Additional laboratory studies may then be
ordered to reﬁne the diagnosis and determine management
options. The results from the semen analysis are categorized
as all parameters normal, oligozoospermia, asthenospermia
(defects in motility), teratozoospermia (defects in morphol-
ogy), and azoospermia (complete lack of sperm).
4.2.1. Interpretation of Normal Semen Parameters. A ﬁnding
of normal semen parameters in the context of infertility
raises the possibility of a female factor, erectile dysfunction,
and/or antisperm antibodies.
5.Diagnosis
5.1. Diﬀerential Diagnosis of Azoospermia. Azoospermia is
categorized as either obstructive or nonobstructive. Nonob-
structive azoospermia refers to a lack of sperm production,
whereas obstructive azoospermia implies adequate sperm
production but failure to deliver the sperm into the ejac-
ulate because of a ductal obstruction. The data on the
testicular size and presence of the vas deferens relate to
this diagnosis, and congenital bilateral absence of the vas
deferens(CBAVD),anobstructiveazoospermia,isdiagnosed
by physical examination.
Atrophictestesmaybeprimary,duetoaninherenttestic-
ulardysfunction,orsecondary,duetoahormonaldeﬁciency.
Azoospermic patients with normal semen volumes and a
palpable vas deferens should have their FSH and testosterone
levels measured. The ﬁnding of small testes in association
with low FSH and testosterone suggests hypogonadotropic
hypogonadism, and the patient’s LH and prolactin levels
should be evaluated as well. Low gonadotropin levels associ-
ated with elevated prolactin raise the possibility of a pituitary
prolactinoma, and a pituitary MRI should be performed.
The ﬁnding of atrophic testes and elevated FSH levels
indicates germ cell failure. Patients with normal sperm
production typically have FSH values in the lower end of the
normal range, and levels above this should raise suspicion
of a defect in spermatogenesis. In addition, patients with
unilateral testicular disease may have elevated FSH levels. A
diagnostic testicular biopsy is not indicated in patients with
elevated FSH levels. Instead, patients with nonobstructive
azoospermia due to a primary testicular defect and not to
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consisting of a karyotype and a Y-chromosome microdele-
tion analysis. If abnormalities are found, a couple should be
oﬀered genetic counseling prior to proceeding with assisted
reproductive techniques.
Normal-sized testes accompanied by normal FSH and
azoospermia suggest the possibility of obstruction, and a
testicular biopsy is required to diﬀerentiate between obstruc-
tion and maturation arrest. If mature sperms are found in
the biopsy, sperm may be cryopreserved for later use in an
IVF/ICSI cycle.
Low-volume azoospermic semen specimens may be
caused by hypogonadism (low testosterone levels), ejacula-
tory duct obstruction, or seminal vesicle absence or hypo-
function. Patients with bilateral ejaculatory duct obstruction
and those with congenital bilateral absence of the vas defer-
ens (CBAVD) produce low-volume, acidic, and azoospermic
semen specimens.
5.2. Multiple Semen Abnormalities. The ﬁnding of defects
in sperm density, motility, and morphology is commonly
referred to as oligoasthenoteratozoospermia (OAT). By far
the most common cause of this pattern is varicocele, which
is a clinical diagnosis determined by a physical examination
and ultrasound study. Additional causes of OAT include
environmental toxins, drugs or medications, and cryptor-
chidism.
5.3. Defects in Isolated Semen Parameters. Complete ejac-
ulatory failure, also called aspermia, exists when no ﬂuid
is produced during the male orgasm, and it is due to
retrograde ejaculation. Common causes of ejaculatory fail-
ure include neurogenic abnormalities, such as spinal cord
injury, diabetes mellitus, multiple sclerosis, and the use
of α-blockers. Retroperitoneal surgeries, including pelvic
surgery and retroperitoneal lymph node dissections, can also
result in impaired ejaculation. True absence of ejaculation
should be diﬀerentiated from the complete inability to
obtain orgasm, which can be caused by medications such
as serotonin reuptake inhibitors and/or by psychological
disturbances. However, much more common than complete
lack of ejaculation are low-volume ejaculate specimens.
The most common cause of this ﬁnding is an incomplete
collection. Complete bilateral ejaculatory duct obstruction
will result in azoospermic, low-volume, and acidic semen
specimens.
5.4. Defects in Sperm Concentration. In patients with less
than 10 × 106 sperm/mL, serum FSH and testosterone levels
should be determined. In patients with less than 5 × 106
sperm/mL, a karyotype and Y-chromosome microdeletion
analysis should be considered as well. Elevated serum
FSH may indicate a primary testicular defect. Although
varicoceles are a common cause of low sperm density, other
abnormal sperm parameters are also usually present with
varicocele.
5.5. Defects in Motility. The term “asthenospermia” refers
to defects in sperm movement. Such cases show only a
low percentage of sperm that have any motility. Antisperm
antibodies and varicoceles may account for this defect.
5.6. Defects in Morphology. The term “teratozoospermia” re-
fers to defects in sperm morphology. This has been reported
with the application of “strict” criteria. The majority of
the cases are idiopathic, while varicoceles and temperature
insults to spermatogenesis are also potential causes.
6. Additional LaboratoryTests
6.1. Hormonal Studies. Hormonal evaluation for male sub-
fertilityisdoneto(1)identifycausativeendocrineabnormal-
ities or (2) obtain prognostic information. Endocrine studies
should include serum levels of PRL, LH, FSH, testosterone,
and E2 (estradiol). As mentioned above, the most common
endocrine abnormality associated with male infertility or
subfertility is elevated FSH, which generally indicates the
impairment of spermatogenesis. However, FSH levels may be
normal in cases of impaired spermatogenesis.
True endocrine causes of male infertility account for less
than 3% of cases [48].
6.2. Antisperm Antibodies. Immunologic infertility is an
autoimmune disorder that can involve both the humoral
and cellular immune system. However, the mechanism is still
poorly understood. Note that other causes may account for
cases of male infertility, even when antisperm antibodies are
detected. Treatment of antisperm antibodies is the use of
ICSI to bypass potential fertilization problems induced by
the antibodies.
7. Conclusions
Whilemanyassayscanbeusedinthediagnosisofmaleinfer-
tility, the foundation of any workup should be obtaining a
detailed history, thorough physical examination, and a basic
semen analysis. Additional tests, including an antisperm
antibody assay and hormonal, karyotype, and ultrasound
studies are needed only to investigate speciﬁc causes of
infertility. In addition, there are some signiﬁcant health
issues which are diagnosed only with presentation of male
infertility, testis tumor and signiﬁcant endocrinopathies
amongst them. A careful evaluation that considers all of
the possible explanations for a man’s infertility is not only
critical for a good diagnosis, it is an ethical imperative for the
reproductive specialist.
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